About Insulin-like growth factor-binding protein 7
Insulin-like growth factor-binding protein 7 (IGFBP7) is a protein
from Homo sapiens identified by UniProt accession
Q16270, 282 residues long.
MolForge cross-references it against 0 known binders and
421 disease associations.
Target properties
| Protein name | Insulin-like growth factor-binding protein 7 |
| UniProt accession | Q16270 |
| Gene | IGFBP7 |
| Organism | Homo sapiens |
| Length | 282 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (421)
Diseases linked to this target (Open Targets).
- familial retinal arterial macroaneurysm · score 0.60
- blood protein measurement · score 0.42
- low density lipoprotein cholesterol measurement · score 0.42
- heel bone mineral density · score 0.38
- insulin-like growth factor-binding protein 7 measurement · score 0.35
- apolipoprotein A 1 measurement · score 0.34
- diastolic blood pressure · score 0.34
- apolipoprotein B measurement · score 0.34
- sleep duration · score 0.34
- refractive error · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16270-F1 | alphafold | PREDICTED | 84.44 | — |
Amino-acid sequence (282 residues)
MERPSLRALL LGAAGLLLLL LPLSSSSSSD TCGPCEPASC PPLPPLGCLL GETRDACGCC PMCARGEGEP CGGGGAGRGY CAPGMECVKS RKRRKGKAGA AAGGPGVSGV CVCKSRYPVC GSDGTTYPSG CQLRAASQRA ESRGEKAITQ VSKGTCEQGP SIVTPPKDIW NVTGAQVYLS CEVIGIPTPV LIWNKVKRGH YGVQRTELLP GDRDNLAIQT RGGPEKHEVT GWVLVSPLSK EDAGEYECHA SNSQGQASAS AKITVVDALH EIPVKKGEGA EL
Explore Insulin-like growth factor-binding protein 7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets